Jefferies Group's CRL Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 5,000 shares of Charles River Laboratories International, Inc. (CRL) worth $782,300, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in CRL, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 12,353 shares. Largest reduction occurred in Q2 2025, reducing 4,742 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2023 | +1,199 | New Buy | 1,199 | $195.98 |
| Q4 2023 | -1,199 | Sold Out | 1,199 | $0.00 |
| Q1 2024 | +8,720 | New Buy | 8,720 | $270.95 |
| Q2 2024 | -8,720 | Sold Out | 8,720 | $0.00 |
| Q3 2024 | +5,449 | New Buy | 5,449 | $196.97 |
| Q4 2024 | +12,353 | Add 226.70% | 17,802 | $184.60 |
| Q1 2025 | -4,188 | Reduce 23.53% | 13,614 | $150.52 |
| Q2 2025 | -4,742 | Reduce 34.83% | 8,872 | $151.73 |
| Q3 2025 | -3,872 | Reduce 43.64% | 5,000 | $156.46 |
Jefferies Group's Charles River Laboratories International Investment FAQs
Jefferies Group first purchased Charles River Laboratories International, Inc. (CRL) in Q3 2023, acquiring 1,199 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Charles River Laboratories International, Inc. (CRL) for 9 quarters since Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q4 2024, adding 17,802 shares worth $3.29 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 5,000 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $782,300. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in Charles River Laboratories International, Inc. (CRL) was 17,802 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.